Health system pharmacy keeps 96% of GLP-1 patients on therapy
Patients receiving injectable GLP-1 therapy through NYU Langone Health Specialty Pharmacy had a 3.9% first-year discontinuation rate, according to research shared Sept. 25 in The American Journal of Managed Care. Here are four things to know: The post Health system pharmacy keeps 96% of GLP-1 patients on therapy appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.